Glenmark Therapeutics launches Olopatadine Hydrochloride Ophthalmic Solution USP
This addition highlights our commitment to meeting market needs and providing high-quality over the-counter solutions for our customers
This addition highlights our commitment to meeting market needs and providing high-quality over the-counter solutions for our customers
Becomes the first rehab & recovery center in east India to earn NABH accreditation
Third approval in China for AstraZeneca and Daiichi Sankyo’s Enhertu in less than two years
Revenue from operations stood at Rs. 313.4 crore during Q1 FY25
Trazodone tablets are indicated for the treatment of major depressive disorder in adults
The sales of medicines and other items sold through Jan Aushadhi Kendras have increased from Rs. 7.29 crore in 2014 to Rs. 1,470 crore by July 2024
The EIR was issued post the last inspection of the facility conducted from May 6-10, 2024 which concluded with zero FDA 483 observations
Expect the international business including CDMO business to pick-up in the second half of the financial year
Organization to provide vaccinations & treatments for several monsoon related diseases and illnesses across all 102 clinics
He advocated for a "PPP + PPP" collaboration, urging the public and private sectors within India to partner with their counterparts in other countries
Subscribe To Our Newsletter & Stay Updated